{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_032409.3:c.926G>A",
          "cDNA Change": {
            "transcript": "NM_032409.3",
            "ref": "G",
            "alt": "A",
            "position": "926"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "309"
          },
          "Description in input context": "PINK1 pathogenic mutations G309D"
        },
        {
          "HGVS": "NM_032409.3:c.1041C>T",
          "cDNA Change": {
            "transcript": "NM_032409.3",
            "ref": "C",
            "alt": "T",
            "position": "1041"
          },
          "Protein Change": {
            "ref": "L",
            "alt": "P",
            "position": "347"
          },
          "Description in input context": "PINK1 pathogenic mutations L347P"
        }
      ]
    },
    {
      "Gene": "PRKN",
      "variants": [
        {
          "HGVS": "NM_000303.3:c.719G>A",
          "cDNA Change": {
            "transcript": "NM_000303.3",
            "ref": "G",
            "alt": "A",
            "position": "719"
          },
          "Protein Change": {
            "ref": "T",
            "alt": "R",
            "position": "240"
          },
          "Description in input context": "parkin T240R"
        },
        {
          "HGVS": "NM_000303.3:c.933C>T",
          "cDNA Change": {
            "transcript": "NM_000303.3",
            "ref": "C",
            "alt": "T",
            "position": "933"
          },
          "Protein Change": {
            "ref": "Q",
            "alt": "X",
            "position": "311"
          },
          "Description in input context": "parkin Q311X"
        },
        {
          "HGVS": "NM_000303.3:c.1244C>A",
          "cDNA Change": {
            "transcript": "NM_000303.3",
            "ref": "C",
            "alt": "A",
            "position": "1244"
          },
          "Protein Change": {
            "ref": "T",
            "alt": "N",
            "position": "415"
          },
          "Description in input context": "parkin T415N"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0000619"
  },
  "Experiment Method": [
    {
      "Assay Method": "Co-immunoprecipitation",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "Human SH-SY5Y cells were used for co-immunoprecipitation analysis."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_032409.3:c.926G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "PINK1 interacts with parkin, and this interaction is not affected by PINK1 pathogenic mutations or kinase-dead mutation."
        },
        {
          "Variant": "NM_032409.3:c.1041C>T",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "PINK1 interacts with parkin, and this interaction is not affected by PINK1 pathogenic mutations or kinase-dead mutation."
        },
        {
          "Variant": "NM_000303.3:c.719G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "The RING-finger 1 domain, but not parkin E3 ligase activity, is required for the interaction of parkin with PINK1."
        },
        {
          "Variant": "NM_000303.3:c.933C>T",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "The RING-finger 1 domain, but not parkin E3 ligase activity, is required for the interaction of parkin with PINK1."
        },
        {
          "Variant": "NM_000303.3:c.1244C>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "The RING-finger 1 domain, but not parkin E3 ligase activity, is required for the interaction of parkin with PINK1."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "In vitro kinase assays",
      "Material used": {
        "Material Source": "Purified proteins",
        "Material Name": "FLAG-tagged PINK1 and Myc-tagged parkin",
        "Description": "In vitro kinase assays were performed by incubation of affinity-purified FLAG-tagged wild-type or mutant PINK1 with Myc-tagged parkin."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_032409.3:c.926G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "PINK1 kinase activity is required for phosphorylation of parkin.",
          "Result Description": "In vitro phosphorylation of parkin by PINK1 was abrogated by PD-linked PINK1 pathogenic mutations G309D and L347P."
        },
        {
          "Variant": "NM_032409.3:c.1041C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "PINK1 kinase activity is required for phosphorylation of parkin.",
          "Result Description": "In vitro phosphorylation of parkin by PINK1 was abrogated by PD-linked PINK1 pathogenic mutations G309D and L347P."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "The reaction mixtures were resolved by SDS–PAGE, and phosphorylation of parkin was determined by immunoblotting with antiphosphoserine and anti-phosphothreonine antibodies."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "The reaction mixtures were resolved by SDS–PAGE, and phosphorylation of parkin was determined by immunoblotting with antiphosphoserine and anti-phosphothreonine antibodies."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "In vivo and in vitro ubiquitination assays",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "In vivo ubiquitination assays were performed as we described previously."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_032409.3:c.926G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "PINK1 kinase activity is required for the ability of PINK1 to promote parkin-mediated IKKg polyubiquitination.",
          "Result Description": "The parkin-mediated IKKg polyubiquitination was significantly increased by co-expression of wild-type PINK1."
        },
        {
          "Variant": "NM_032409.3:c.1041C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "PINK1 kinase activity is required for the ability of PINK1 to promote parkin-mediated IKKg polyubiquitination.",
          "Result Description": "The parkin-mediated IKKg polyubiquitination was significantly increased by co-expression of wild-type PINK1."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "All experiments were performed in triplicate and repeated at least three times."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "All experiments were performed in triplicate and repeated at least three times."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "The reaction mixtures were resolved by SDS–PAGE, and ubiquitination was detected by immunoblotting."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "The reaction mixtures were resolved by SDS–PAGE, and ubiquitination was detected by immunoblotting."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA",
        "Description": "Data were subjected to statistical analysis by ANOVA and a P-value of less than 0.05 was considered statistically significant."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}